Evidence map›Paper›PMID 28931371›Full record

ArticleBMC bioinformatics2017

VISMapper: ultra-fast exhaustive cartography of viral insertion sites for gene therapy.

José M Juanes, Asunción Gallego, Joaquín Tárraga, Felipe J Chaves, Pablo Marín-Garcia, Ignacio Medina, Vicente Arnau, Joaquín Dopazo

Abstract read
In one paragraph

Article in BMC bioinformatics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

José M JuanesDepartamento de Informática, Escuela Técnica Superior de Ingeniería (ETSE), Universidad de Valencia, 46100, Valencia, Burjassot, Spain.
Asunción GallegoClinical Bioinformatics Research Area, Fundación Progreso y Salud, Hospital Virgen del Rocío, 41013, Sevilla, Spain.
Joaquín TárragaComputational Genomics Department, Prince Felipe Research Center, 46012, Valencia, Spain.
Felipe J ChavesGenotyping and Genetic Diagnosis Unit, Health Research Institute, INCLIVA, Valencia, Spain.
Pablo Marín-GarciaGenotyping and Genetic Diagnosis Unit, Health Research Institute, INCLIVA, Valencia, Spain.
Ignacio MedinaHPC Service, University Information Services, University of Cambridge, Cambridge, UK.
Vicente ArnauDepartamento de Informática, Escuela Técnica Superior de Ingeniería (ETSE), Universidad de Valencia, 46100, Valencia, Burjassot, Spain.
Joaquín DopazoClinical Bioinformatics Research Area, Fundación Progreso y Salud, Hospital Virgen del Rocío, 41013, Sevilla, Spain. joaquin.dopazo@juntadeandalucia.es.ORCID http://orcid.org/0000-0003-3318-120X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe possibility of integrating viral vectors to become a persistent part of the host genome makes them a crucial element of clinical gene therapy. However, viral integration has associated risks, such as the unintentional activation of oncogenes that can result in cancer. Therefore, the analysis of integration sites of retroviral vectors is a crucial step in developing safer vectors for therapeutic use.

resultsHere we present VISMapper, a vector integration site analysis web server, to analyze next-generation sequencing data for retroviral vector integration sites. VISMapper can be found at: http://vismapper.babelomics.org .

conclusionsBecause it uses novel mapping algorithms VISMapper is remarkably faster than previous available programs. It also provides a useful graphical interface to analyze the integration sites found in the genomic context.

Indexed as

User-Computer InterfaceBase SequenceGenetic TherapyGenetic VectorsHigh-Throughput Nucleotide SequencingHumansInternetVirus IntegrationGene therapyGenome viewerSequence mappingViral insertionViral integration

Identifiers

PMID28931371
PMCPMC5607581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.